UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 14, 2011

ProUroCare Medical Inc.
(Exact Name of Registrant as Specified in its Charter)

Nevada
000-51774
20-1212923
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
 
6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota  55416
(Address of Principal Executive Offices)  (Zip Code)
 
(952) 476-9093
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 

 
 
 

Item 1.01  Entry into Material Definitive Agreements

On January 14, 2011, ProUroCare Medical Inc. (the “Company”) renewed its existing $100,025 promissory note with Central Bank for an additional one-year term.  The promissory note matures on January 17, 2012 and bears interest at the Prime Rate plus 1.0%, with a minimum rate of 6.0%.  The promissory note remains guaranteed by Bruce Johnson.  The Company’s existing security agreement with Mr. Johnson, which provides him with a subordinated security interest in the Company’s assets, will remain in effect until the Central Bank promissory note is retired.
 
Item 2.03  Creation of a Direct financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Company
 
See Item 1.01 above.
 
 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ProUroCare Medical Inc.
  
       
Date: January 21, 2011
By
/s/ Richard C. Carlson  
    Richard C. Carlson  
    Chief Executive Officer